CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851170950
- Phone
- 737 203 5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- 4 Open-market buy Director bought 412 shares at $5.90 ($2,429)
- 4 Open-market buy Director bought 4,500 shares at $5.93 ($26,685)
- 4 Open-market buy Director bought 13,836 shares at $5.30 ($73,331)
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4/A Grant or award Director acquired 714,250 shares (grant or award)
- SC 13D Stake Beneficial Ownership Report
- 424B4 Offering Prospectus
- 4 Grant or award Director acquired 714,286 shares (grant or award)
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 9 of 11 · 204 filings